WFG Advisors’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-40
Closed 1769
2016
Q3
$0 Hold
40
﹤0.01% 1718
2016
Q2
$0 Hold
40
﹤0.01% 1718
2016
Q1
$0 Hold
40
﹤0.01% 1715
2015
Q4
$1K Hold
40
﹤0.01% 1507
2015
Q3
$0 Hold
40
﹤0.01% 1735
2015
Q2
$1K Hold
40
﹤0.01% 1602
2015
Q1
$0 Hold
40
﹤0.01% 2118
2014
Q4
$0 Hold
40
﹤0.01% 2269
2014
Q3
$0 Hold
40
﹤0.01% 2182
2014
Q2
$0 Hold
40
﹤0.01% 2089
2014
Q1
$1K Hold
40
﹤0.01% 1922
2013
Q4
$1K Sell
40
-6,175
-99% -$94.9K ﹤0.01% 2146
2013
Q3
$106K Buy
6,215
+1,000
+19% +$17.6K 0.02% 691
2013
Q2
$87K Buy
+5,215
New +$84.5K 0.01% 711

Other funds holding IMGN

WFG Advisors's IMGN Position: Q4 2016 in Review

WFG Advisors sold out of Immunogen Inc (IMGN) in Q4 2016, closing a stake of 40 shares.

WFG Advisors first reported a position in IMGN in Q2 2013 and held it in 14 quarters. The position peaked at $106K in Q3 2013. 156 funds tracked by Wall St. Rank hold IMGN as of Q4 2016.

  • WFG Advisors reported no remaining Immunogen Inc position as of Q4 2016 after selling out during the quarter.
  • WFG Advisors sold 40 Immunogen Inc shares in Q4 2016.
  • WFG Advisors first reported a position in Immunogen Inc in Q2 2013 and held it in 14 quarters.
  • WFG Advisors's Immunogen Inc position peaked at $106K in Q3 2013.
  • 156 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2016.

Based on WFG Advisors's 13F filing for Q4 2016, filed 1 Mar 2017.